Insider Trading: Rexahn Pharmaceuticals Inc (RNN)
RNN on American Stock Exchange
0.35USD
21 May 2013
0.35USD
21 May 2013
Price Change (% chg)
$0.04 (+12.83%)
$0.04 (+12.83%)
Prev Close
$0.31
$0.31
Open
$0.33
$0.33
Day's High
$0.35
$0.35
Day's Low
$0.31
$0.31
Volume
1,651,549
1,651,549
Avg. Vol
377,061
377,061
52-wk High
$0.81
$0.81
52-wk Low
$0.28
$0.28
| AHN CHANG HO | Options Exercised: 0 | ||
| Trade Date: | Monday, 19 Dec 2011 | Price: | 0.00 |
| Title: | Chief Executive Officer | Shares Held: | 11,313,924 |
| Type Traded: | Direct | Net Change in Shares This Filing: | -4,525,000 |
Institutional Holders
| % Shares Owned: | 2.53% |
| # of Holders: | 21 |
| Total Shares Held: | 3,017,640 |
| 3 Mo. Net Change: | -10,345,462 |
| # New Positions: | 4 |
| # Closed Positions: | 6 |
| # Increased Positions: | 6 |
| # Reduced Positions: | 9 |
| # Net Buyers: | -3 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Chang Ahn |
60 | 2013 | Chairman of the Board, Chief Scientist |
Rakesh Soni |
56 | 2009 | President, Chief Operating Officer |
Peter Suzdak |
2013 | Chief Executive Officer | |
Tae Heum Jeong |
41 | 2012 | Chief Financial Officer, Secretary |
Charles Beever |
59 | 2006 | Independent Director |
Peter Brandt |
56 | 2010 | Independent Director |
Kwang Soo Cheong |
51 | 2006 | Independent Director |
Richard Kivel |
45 | 2010 | Independent Director |
David McIntosh |
53 | 2005 | Independent Director |
Stephanie Ascher |
IR Contact Officer |

